FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2094702489> ?p ?o ?g. }

• W2094702489 endingPage "1077" @default.
• W2094702489 startingPage "1072" @default.
• W2094702489 abstract "Polyethylene glycol-conjugated (PEG) asparaginase is approved for use in patients who develop allergy to other forms of asparaginase, although its ability to deplete asparagine systemically in patients with hypersensitivity has not been well elucidated. In 53 children with newly diagnosed acute lymphoblastic leukemia, we serially assessed asparagine concentrations in cerebrospinal fluid (CSF) and plasma as well as serum anti-asparaginase antibodies. All patients received native Escherichia coli (Elspar) asparaginase during induction therapy; patients received PEG asparaginase during reinductions when available, and those who developed allergy received Erwinia asparaginase. All eight patients who developed clinical evidence of allergy to asparaginase had anti-asparaginase antibodies. Among patients who had no antibodies, those who received E. coli had lower mean (+/-s.d.) CSF asparagine (0.29+/-0.63, n=9) than those who received PEG (0.77+/-0.82, n=4) (P=0.007). Results were similar for plasma asparagine. There was no situation where asparagine concentrations were more effectively depleted by PEG than by other preparations. None of the five patients who developed thrombosis had an allergy or antibodies to asparaginase at the time of the thrombosis. We conclude that asparagine concentrations were less effectively depleted by PEG than by E. coli asparaginase at the doses commonly used. The risk of thrombosis may be affected by the intensity of asparaginase exposure." @default.
• W2094702489 created "2016-06-24" @default.
• W2094702489 creator A5007925658 @default.
• W2094702489 creator A5023023538 @default.
• W2094702489 creator A5060815495 @default.
• W2094702489 creator A5063344928 @default.
• W2094702489 creator A5065634145 @default.
• W2094702489 creator A5069929441 @default.
• W2094702489 creator A5083433284 @default.
• W2094702489 creator A5087567702 @default.
• W2094702489 date "2004-04-01" @default.
• W2094702489 modified "2023-10-17" @default.
• W2094702489 title "Asparaginase pharmacodynamics differ by formulation among children with newly diagnosed acute lymphoblastic leukemia" @default.
• W2094702489 cites W1887863677 @default.
• W2094702489 cites W1940732706 @default.
• W2094702489 cites W1944430150 @default.
• W2094702489 cites W1965769627 @default.
• W2094702489 cites W1970593462 @default.
• W2094702489 cites W1974895424 @default.
• W2094702489 cites W2005688611 @default.
• W2094702489 cites W2010064279 @default.
• W2094702489 cites W2016822528 @default.
• W2094702489 cites W2018573935 @default.
• W2094702489 cites W2024241872 @default.
• W2094702489 cites W2040730344 @default.
• W2094702489 cites W2049552282 @default.
• W2094702489 cites W2058713665 @default.
• W2094702489 cites W2080828049 @default.
• W2094702489 cites W2103347449 @default.
• W2094702489 cites W2117623554 @default.
• W2094702489 cites W2127153931 @default.
• W2094702489 cites W2156945455 @default.
• W2094702489 cites W2336096370 @default.
• W2094702489 cites W2400065648 @default.
• W2094702489 cites W4242108431 @default.
• W2094702489 doi "https://doi.org/10.1038/sj.leu.2403351" @default.
• W2094702489 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/15057247" @default.
• W2094702489 hasPublicationYear "2004" @default.
• W2094702489 type Work @default.
• W2094702489 sameAs 2094702489 @default.
• W2094702489 citedByCount "57" @default.
• W2094702489 countsByYear W20947024892012 @default.
• W2094702489 countsByYear W20947024892014 @default.
• W2094702489 countsByYear W20947024892015 @default.
• W2094702489 countsByYear W20947024892016 @default.
• W2094702489 countsByYear W20947024892018 @default.
• W2094702489 countsByYear W20947024892019 @default.
• W2094702489 countsByYear W20947024892020 @default.
• W2094702489 countsByYear W20947024892021 @default.
• W2094702489 countsByYear W20947024892022 @default.
• W2094702489 countsByYear W20947024892023 @default.
• W2094702489 crossrefType "journal-article" @default.
• W2094702489 hasAuthorship W2094702489A5007925658 @default.
• W2094702489 hasAuthorship W2094702489A5023023538 @default.
• W2094702489 hasAuthorship W2094702489A5060815495 @default.
• W2094702489 hasAuthorship W2094702489A5063344928 @default.
• W2094702489 hasAuthorship W2094702489A5065634145 @default.
• W2094702489 hasAuthorship W2094702489A5069929441 @default.
• W2094702489 hasAuthorship W2094702489A5083433284 @default.
• W2094702489 hasAuthorship W2094702489A5087567702 @default.
• W2094702489 hasBestOaLocation W20947024891 @default.
• W2094702489 hasConcept C10138342 @default.
• W2094702489 hasConcept C126322002 @default.
• W2094702489 hasConcept C159654299 @default.
• W2094702489 hasConcept C162324750 @default.
• W2094702489 hasConcept C203014093 @default.
• W2094702489 hasConcept C2775895851 @default.
• W2094702489 hasConcept C2778461978 @default.
• W2094702489 hasConcept C2778904437 @default.
• W2094702489 hasConcept C2781107101 @default.
• W2094702489 hasConcept C2909962599 @default.
• W2094702489 hasConcept C515207424 @default.
• W2094702489 hasConcept C54400483 @default.
• W2094702489 hasConcept C55493867 @default.
• W2094702489 hasConcept C71924100 @default.
• W2094702489 hasConcept C86803240 @default.
• W2094702489 hasConcept C90924648 @default.
• W2094702489 hasConcept C98274493 @default.
• W2094702489 hasConceptScore W2094702489C10138342 @default.
• W2094702489 hasConceptScore W2094702489C126322002 @default.
• W2094702489 hasConceptScore W2094702489C159654299 @default.
• W2094702489 hasConceptScore W2094702489C162324750 @default.
• W2094702489 hasConceptScore W2094702489C203014093 @default.
• W2094702489 hasConceptScore W2094702489C2775895851 @default.
• W2094702489 hasConceptScore W2094702489C2778461978 @default.
• W2094702489 hasConceptScore W2094702489C2778904437 @default.
• W2094702489 hasConceptScore W2094702489C2781107101 @default.
• W2094702489 hasConceptScore W2094702489C2909962599 @default.
• W2094702489 hasConceptScore W2094702489C515207424 @default.
• W2094702489 hasConceptScore W2094702489C54400483 @default.
• W2094702489 hasConceptScore W2094702489C55493867 @default.
• W2094702489 hasConceptScore W2094702489C71924100 @default.
• W2094702489 hasConceptScore W2094702489C86803240 @default.
• W2094702489 hasConceptScore W2094702489C90924648 @default.
• W2094702489 hasConceptScore W2094702489C98274493 @default.
• W2094702489 hasIssue "6" @default.
• W2094702489 hasLocation W20947024891 @default.
• W2094702489 hasLocation W20947024892 @default.

• next